Lista de obras -

Author's Response to: 'Letter to the Editor in Response to: "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally"'

scientific article published on 24 December 2019

CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention.

artículo científico publicado en 2019

Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants

artículo científico publicado en 2018

Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects

artículo científico publicado en 2020

Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally

scientific article published on 03 September 2019

Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.

artículo científico publicado en 2017

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates

scientific article published on 22 April 2020

Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers

scientific article published on 01 October 2019

Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects

artículo científico publicado en 2018

Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis.

artículo científico publicado en 2017

Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling

scientific article published on 17 September 2020

Histone modifications associated with biological drug response in moderate-to-severe psoriasis

scientific article published on 01 December 2018

How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?

article

Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19)

artículo científico publicado en 2020

Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers

scientific article published on 18 October 2019

Influence of CYP2C19 phenotype on the effect of clopidogrel in patients undergoing percutaneous neurointervention procedure.

artículo científico publicado en 2018

Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

artículo científico publicado en 2018

Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention

artículo científico publicado en 2019

Influence of tpmt polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers

scientific article published on 15 November 2018

Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics

artículo científico publicado en 2020

Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial

artículo científico publicado en 2020

Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis

artículo científico publicado en 2017

Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safety

artículo científico publicado en 2017

Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.

artículo científico publicado en 2017

Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis.

artículo científico publicado en 2017

Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects

artículo científico publicado en 2018

Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics

scientific article published on 21 February 2019

Prediction models for voriconazole pharmacokinetics based on pharmacogenetics: AN exploratory study in a Spanish population

scientific article published on 04 July 2019

Risk of COVID-19 in oncohematological patients

artículo científico publicado en 2020

Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

artículo científico publicado en 2020

Simultaneous determination of six antipsychotics, two of their metabolites and caffeine in human plasma by LC-MS/MS using a phospholipid-removal microelution-solid phase extraction method for sample preparation

scientific article published on 01 February 2019

Lista de obras de

Author's Response to: 'Letter to the Editor in Response to: "Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally"'

CYP2C19 Ultrarapid Phenotype as a Risk Predictor of Subsequent Events During Clopidogrel Treatment in Patients Undergoing a Percutaneous Neurointervention.

Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants

Effect of Cytochrome P450 and ABCB1 Polymorphisms on Imatinib Pharmacokinetics After Single-Dose Administration to Healthy Subjects

Effect of Polymorphisms in CYP2C9 and CYP2C19 on the Disposition, Safety and Metabolism of Progesterone Administrated Orally or Vaginally

Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates

Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers

Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects

Epigenetic biomarkers associated with antitumour necrosis factor drug response in moderate-to-severe psoriasis.

Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling

Histone modifications associated with biological drug response in moderate-to-severe psoriasis

How to make P-glycoprotein (ABCB1, MDR1) harbor mutations and measure its expression and activity in cell cultures?

Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19)

Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers

Influence of CYP2C19 phenotype on the effect of clopidogrel in patients undergoing percutaneous neurointervention procedure.

Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention

Influence of tpmt polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers

Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics

Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial

Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis

Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safety

Polymorphisms associated with adalimumab and infliximab response in moderate-to-severe plaque psoriasis.

Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis.

Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects

Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics

Prediction models for voriconazole pharmacokinetics based on pharmacogenetics: AN exploratory study in a Spanish population

Risk of COVID-19 in oncohematological patients

Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Simultaneous determination of six antipsychotics, two of their metabolites and caffeine in human plasma by LC-MS/MS using a phospholipid-removal microelution-solid phase extraction method for sample preparation